Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Nail changes are common in alopecia areata and can indicate its severity.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Disulfide bonds are crucial for hair's strength, especially when wet.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.